(S)-1-BENZYL-4-TERT.-BUTYL-2-[2-(2-TOLYL-PHOSPHANYL)-PHENYL]-4,5-DIHYDROIMIDAZOLE
Compound with spectra: 1 NMR
![(S)-1-BENZYL-4-TERT.-BUTYL-2-[2-(2-TOLYL-PHOSPHANYL)-PHENYL]-4,5-DIHYDROIMIDAZOLE](/api/compound/AQySXIJeE8s.png?ph=true&h=300&w=458 "(S)-1-BENZYL-4-TERT.-BUTYL-2-[2-(2-TOLYL-PHOSPHANYL)-PHENYL]-4,5-DIHYDROIMIDAZOLE")
| SpectraBase Compound ID | AQySXIJeE8s |
|---|---|
| InChI | InChI=1S/C34H37N2P/c1-25-15-9-12-20-29(25)37(30-21-13-10-16-26(30)2)31-22-14-11-19-28(31)33-35-32(34(3,4)5)24-36(33)23-27-17-7-6-8-18-27/h6-22,32H,23-24H2,1-5H3/t32-/m1/s1 |
| InChIKey | UNKOPYJVOCIZEV-JGCGQSQUSA-N |
| Mol Weight | 504.7 g/mol |
| Molecular Formula | C34H37N2P |
| Exact Mass | 504.269436 g/mol |
| Enantiomer InChIKey | UNKOPYJVOCIZEV-YTTGMZPUSA-N |
| Racemate InChIKey | UNKOPYJVOCIZEV-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(S)-4-TERT.-BUTYL-2-(2-DIPHENYLPHOSPHANYL-PHENYL)-1-(4-TRIFLUOROMETHYL-PHENYL)-4,5-DIHYDROIMIDAZOLE
(S)-4-TERT.-BUTYL-1-(4-METHOXYPHENYL)-2-(2-DIPHENYLPHOSPHANYL-PHENYL)-4,5-DIHYDROIMIDAZOLE
(S)-4-TERT.-BUTYL-1-PHENYL-2-(2-DIPHENYLPHOSPHANYL-PHENYL)-4,5-DIHYDROIMIDAZOLE
(S)-4-TERT.-BUTYL-2-(2-DIPHENYLPHOSPHANYL-PHENYL)-1-(4-TOLYL)-4,5-DIHYDROIMIDAZOLE
(4R,5R)-2-(2-DIPHENYLPHOSPHANYLPHENYL)-4,5-DIPHENYL-4,5-DIHYDRO-1H-IMIDAZOLE
4-(Isopropyl)-2-[2'-(diphenylphosphino)phenyl]-4H-1,3-benzoxazine
N-Benzyl-4-methyl-1-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl-1-phenyl-ethanone
(S)-4-((di-o-tolylphosphino)methyl)-2-(3,5-dimethylphenyl)-4,5,6,7-tetrahydrobenzo[d]thiazole
Irbesartan ME
8-Trifluoromethyl-11-(4-ethylpiperazin-1-yl)-dibenzo[b,f][1,4]oxazepine
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Application of Chiral Phosphino-Imidazoline Ligands: Ir-Catalyzed Enantioselective Hydrogenation | Organic Letters | 2002 |